---
title: "Aptorum files amended 8-K updating DiamiR Biosciences financial statements"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296654284.md"
description: "Aptorum filed an amended 8-K updating DiamiR Biosciences' financial statements, which revealed substantial doubt about its ability to continue as a going concern due to working capital deficiencies and operating losses. As of May 31, 2026, DiamiR reported total assets of $618,078 against liabilities of $2.21 million and a net loss of $659,936. The filing also confirmed the July 20, 2026, closing of Aptorum's merger with DiamiR, followed by Aptorum's domestication and name change to Niki BioSolutions."
datetime: "2026-08-21T21:18:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296654284.md)
  - [en](https://longbridge.com/en/news/296654284.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296654284.md)
generator: "portal-rs"
---

# Aptorum files amended 8-K updating DiamiR Biosciences financial statements

-   Aptorum filed an amended current report that restated its disclosure to include DiamiR Biosciences’ audited consolidated financial statements for the years ended May 31, 2026 and May 31, 2025. \* The audit report flagged substantial doubt about DiamiR’s ability to continue as a going concern, citing a significant working capital deficiency and ongoing operating losses. \* DiamiR reported total assets of $618,078 at May 31, 2026, versus total liabilities of $2.21 million. \* DiamiR posted a net loss of $659,936 for the year ended May 31, 2026, versus $743,235 a year earlier. \* The filing also described the July 20, 2026 closing of Aptorum’s merger with DiamiR and Aptorum’s domestication and name change to Niki BioSolutions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-092689), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [APM.US](https://longbridge.com/en/quote/APM.US.md)
- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)

## Related News & Research

- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)
- [J.M. Smucker announces dividend of R$ 1.94 per unit for Q3 2026](https://longbridge.com/en/news/297931100.md)
- [LyondellBasell announces dividend of R$ 1.72 per unit for 3Q 2026](https://longbridge.com/en/news/297814383.md)
- [PulteGroup declares Q3 2026 dividend of R$ 0.9 per unit](https://longbridge.com/en/news/297931957.md)
- [Equillium to join Cantor Global Healthcare Conference 2026 fireside chat](https://longbridge.com/en/news/297786721.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**